Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Standigm Announces Younsung Choo as Chief Executive Officer (CEO)
Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that Younsung […]
Nerivio® Proven Effective in Real-World Setting as Drug-Free Acute Treatment of Migraine for Adolescents
Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain […]
Center for Breakthrough Medicines Now Provides a Clinically Tested Adherent Manufacturing Platform for AAV Production
The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to […]
MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan
MyMD Pharmaceuticals, a clinical-stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and […]
Geneos Therapeutics Secures $5 Million in Series A3 Financing
Geneos Therapeutics, a clinical-stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines […]
Junshi Biosciences Announces Phase 3 Clinical Study of Senaparib for Advanced Ovarian Cancer Maintenance Treatment
Shanghai Junshi Biosciences (TopAlliance), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and […]
Collective Health Announces Appointment of Dr. Linda Grais to Board of Directors
Collective Health has announced the addition of Dr Linda Grais, a seasoned physician and biopharma […]
VintaBio Unveils $64M to Back Viral Vector Trailblazers Behind the First Approved Cell and Gene Therapies
VintaBio, a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck […]
Taros Chemicals and Welab Barcelona Announce Partnership to Provide Integrated Drug Discovery Services
Taros Chemicals, a leading German contract research (CRO) player in small molecules, and Welab Barcelona, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more